Clinical Trial Update: Heterologous Effects of BCG in Healthy UK Adults [NA]

View source ↗

Summary

Completed clinical trial from the University of Oxford assessing non-specific (heterologous) immune effects of the BCG vaccine in healthy UK adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | NA | Status: COMPLETED